APOE and Alzheimer disease: In conclusion, these novel epistatic interactions between APOE, LSR and VEGF-A related polymorphisms allow for prediction of AD risk, constituting not only a useful prediction model, but also providing new insights about molecular mechanisms that can be involved in AD development which could be useful as biomarkers and/or treatment targets.